AGEN: Agenus, Inc. Sotuvga nisbatan narx
Agenus immuno-onkologiya sohasida yetakchilik qilmoqda, litsenziyalash shartnomalari va hamkorlarning bosqichma-bosqich to'lovlari orqali kapital jalb qilmoqda. Sotuvlarga nisbatan narx koeffitsiyenti biznesning baholanish dinamikasini aks ettiradi, bunda 2.30 qiymati joriy ko'rsatkich vazifasini o'taydi. Yetakchi olimlar jamoasi innovatsion saratonga qarshi agentlarni ishlab chiqmoqda. Platformaga bog'liqlik risklarini kamaytirish uchun Agenus global sog'liqni saqlash gigantlariga royalti huquqlarini sotish orqali eski patentlarni monetizatsiya qilmoqda.
Agenus Inc (AGEN) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Agenus|AGEN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Agenus, Inc|AGEN - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Agenus Inc|AGEN - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Agenus|Tezkor likvidlik koeffitsiyenti agenusbio.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
AGEN - Sof foyda|Prognoz qilingan sof foyda Agenus|AGEN - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Agenus, Inc.|AGEN - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Agenus Inc|AGEN - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bitta aksiya uchun foyda Agenus|AGEN - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi agenusbio.com|AGEN - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Agenus
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning jamlanma tahliliyoti:AGEN agenusbio.com
Agenus (AGEN) kompaniyasining muvaffaqiyati saratonning yangi immunoterapiya usullarini tartibga soluvchi organlar tomonidan tasdiqlanishiga va sheriklik kelishuvlarining samaradorligiga bog'liq. Tarixiy P/S tendentsiyasini tahlil qilish orqali investor bozor kapitalizatsiyasining yillik daromadga nisbatini baholaydi, bu esa inflyatsiyaviy xavflarga va marjalarning o'zgarishiga bozorning joriy kayfiyatini real vaqt rejimida baholash imkonini beradi, natijada kelajakdagi biznes o'sishi uchun to'langan premium miqdori aniqlanadi.
Agenus raqobatchilari
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|PTGX - P/S multiplikatori|IMVT: P/S multiplikatori|Narx/daromad multiplikatori kiniksa.com KNSA|GRFS (Grifols) - P/S multiplikatori|Sotuvga nisbatan narx Adaptive Biotech ADPT|Narxning daromadga nisbati Celldex (CLDX)|Aurinia Corp - Kapitalizatsiya va daromad nisbati|BioCryst - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori veratx.com VERA|DNTH - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Pharvaris NV PHVS|ABCL: P/S multiplikatori|Tourmaline (TRML) - P/S multiplikatori|PGEN (Precigen, Inc.) - P/S multiplikatori|PHAR - Narx/daromad multiplikatori|P/S multiplikatori NKTR|UPB - Sotuvga nisbatan narx|Narxning daromadga nisbati Zenas Biopharma, Inc. ZBIO|IMNM: Kapitalizatsiya va daromad nisbati|GOSS - Narxning daromadga nisbati|Narxning sotuvga nisbati KALV|SEPN: P/S multiplikatori|Pieris Pharma - Bozor kapitallashuvining daromadga nisbati|SVRA (Savara Corp) - P/S multiplikatori|P/S multiplikatori Rigel Corp|Narxning daromadga nisbati AnaptysBio, Inc. (ANAB)|ATXS (astriatx.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati enGene ENGN|RAPT - Kapitalizatsiyaning daromadga nisbati|Aerovate - P/S multiplikatori|ACRS - P/S multiplikatori|KYTX (Kyverna Therapeutics) - Kapitalizatsiyaning daromadga nisbati|tizianalifesciences.com - Bozor kapitallashuvining daromadga nisbati|CABA (Cabaletta Bio) - P/S multiplikatori|Ventyx Biosciences Inc. (VTYX) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Theratechnologies Inc (THTX)|Kapitalizatsiyaning daromadga nisbati Avalo Therapeutics Inc AVTX|Narxning daromadga nisbati Eledon Pharmaceuticals ELDN|CLYM - Kapitalizatsiyaning daromadga nisbati|ZURA: Kapitalizatsiyaning daromadga nisbati|ATYR - P/S multiplikatori|adagene.com (ADAG) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati IMA|STTK (Shattuck Labs Inc) - P/S multiplikatori|Sotuvga nisbatan narx Equillium Bio EQ|P/S multiplikatori CNTB|P/S multiplikatori immunic-therapeutics.com (IMUX)|P/S multiplikatori ATRA (Atara Bio)|Narx/daromad multiplikatori InflaRx NV|X4 Pharmaceuticals - P/S multiplikatori|Sotuvga nisbatan narx Adicet Bio|celularity.com (CELU) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati INMB|Kapitalizatsiyaning daromadga nisbati BRNS|P/S multiplikatori Kezar Life Sciences Inc|Narxning daromadga nisbati SAB Biotherapeutics (SABS)|Narx/daromad koeffitsiyenti akaritx.com|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd.)|P/S multiplikatori Q32 Bio Inc QTTB|GeoVax Labs Inc - P/S multiplikatori|Narx/daromad multiplikatori Edesa Biotech Corp (EDSA)|IBIO: P/S multiplikatori|Sotuvga nisbatan narx Carisma Therapeutics Inc. (CARM)|Narxning daromadga nisbati XTL Biopharmaceuticals Ltd.|Kapitalizatsiya va daromad nisbati BOLT (Bolt Bio)|Narxning daromadga nisbati HCW Biologics Inc. (HCWB)|APVO: Narxning sotuvga nisbati|P/S multiplikatori AIM (AIM ImmunoTech Inc.)|Bozor kapitallashuvining daromadga nisbati ADTX|GRI Bio - P/S multiplikatori|XRTX - P/S multiplikatori|ReShape Lifesciences (HIND) - Narxning daromadga nisbati|Revelation Biosciences Corp - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Indaptus Therapeutics|Kapitalizatsiyaning daromadga nisbati scinai.com (SCNI)|P/S multiplikatori CALI|P/S multiplikatori affimed.com (AFMD)|Allakos - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati HOOK|IGM Bio - P/S multiplikatori|Narx/daromad koeffitsiyenti iteostherapeutics.com ITOS|Ocean Biomedical (OCEA) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati TC BioPharm (Holdings) Plc|Narxning daromadga nisbati Third Harmonic Bio, Inc
